Regulation of Lipid-Droplet Transport by the Perilipin Homolog LSD2  by Welte, Michael A. et al.
Current Biology, Vol. 15, 1266–1275, July 26, 2005, ©2005 Elsevier Ltd All rights reserved. DOI 10.1016/j.cub.2005.06.062
Regulation of Lipid-Droplet Transport
by the Perilipin Homolog LSD2Michael A. Welte,1,2,6 Silvia Cermelli,5,6 John Griner,1
Arturo Viera,5 Yi Guo,1,3 Dae-Hwan Kim,1,2
Joseph G. Gindhart,4 and Steven P. Gross5,*
1Rosenstiel Biomedical Research Center
2Department of Biology
3Department of Biochemistry
Brandeis University
415 South Street
Waltham, Massachusetts 02454
4Department of Biology
University of Richmond
28 Westhampton Way
Richmond, Virginia 23173
5Department of Developmental and Cell Biology
2222 Natural Sciences I
University of California, Irvine
Irvine, California 92697
Summary
Background: Motor-driven transport along microtu-
bules is a primary mechanism for moving and position-
ing organelles. How such transport is regulated remains
poorly understood. For lipid droplets in Drosophila em-
bryos, three distinct phases of transport can be distin-
guished. To identify factors regulating this transport, we
biochemically purified droplets from individual phases
and used 2D gel analysis to search for proteins whose
amount on droplets changes as motion changes.
Results: By mass spectrometry, we identified one such
protein as LSD2. Similar to its mammalian counterpart
Perilipin, LSD2 is responsible for regulating lipid ho-
meostasis. Using specific antibodies, we confirmed
that LSD2 is present on embryonic lipid droplets. We
find that lack of LSD2 causes a specific transport de-
fect: Droplet distribution fails to undergo the dramatic
changes characteristic of the wild-type. This defect is
not due to a complete failure of the core transport ma-
chinery—individual droplets still move bidirectionally
along microtubules with approximately normal veloci-
ties and kinetics. Rather, detailed biophysical analysis
suggests that developmental control of droplet motion
is lost. We show that LSD2 is multiply phosphorylated
in a developmentally controlled manner. LSD2 phos-
phorylation depends on the transacting signal Halo,
and LSD2 can physically interact with the lipid-droplet-
associated coordinator Klar, identifying LSD2 as a
central player in the mechanisms that control droplet
motion.
Conclusions: LSD2 appears to represent a new class
of regulators, a protein that transduces regulatory sig-
nals to a separable core motor machinery. In addition,
the demonstration that LSD2 regulates both transport
and lipid metabolism suggests a link between lipid-
droplet motion and lipid homeostasis.*Correspondence: sgross@uci.edu
6 These authors contributed equally to this work.Introduction
Motor-driven transport along microtubules positions
and delivers many cellular organelles, including the ER,
Golgi, mitochondria, axonal vesicles, and nuclei. Many
cargoes move in a bidirectional manner: They engage
in repeated short back-and-forth movements [1, 2], al-
ternately using plus-end (e.g., kinesin-1 and kinesin-2)
and minus-end motors (typically cytoplasmic dynein).
Net, or average, transport depends on the balance of
plus- and minus-end-directed motion.
Such transport is often dynamically regulated. For
example, mitochondria move to growth cones where
ATP is needed [3]; viruses change their motion between
initial infection and subsequent spread [4, 5]; and pig-
ment granules disperse or aggregate to camouflage
fish or frogs [6]. The motion of different cargoes in the
same cell can be controlled independently, although
the cargoes move in the same cytoplasm and often em-
ploy the same set of motors. Thus, multiple levels of
regulation control timing, direction, and cargo specific-
ity of transport.
In a few model systems, key transport regulators
have been identified. For example, net pigment granule
transport is controlled by protein kinase A [7, 8], and
mitochondrial accumulation requires signaling through
the PI-3 kinase pathway [3, 9]. However, the down-
stream targets of these kinases are not known.
To dissect these regulatory mechanisms, we investi-
gated lipid-droplet motion in early Drosophila embryos.
Past work with genetic, molecular, and biophysical ap-
proaches identified four molecules important for drop-
let transport: the minus-end motor cytoplasmic dynein
[10] and its cofactor dynactin [11], the proposed coordi-
nator Klar [12, 13], and the transacting signal Halo [14].
How these molecules work together mechanistically
has not yet been established. Halo is a novel molecule
of unknown molecular function. Klar is physically asso-
ciated with lipid droplets, and lack of Klar appears to
cause a breakdown in motor coordination, yet Klar’s
sequence has provided few mechanistic insights. Fi-
nally, unlike in other systems, there is as yet no evi-
dence that protein kinases play roles in regulating drop-
let motion.
Lipid droplets are not a specialization of Drosophila
embryos. They are ubiquitous organelles present in
most eukaryotic cells, from yeast to plants to mammals
[15–17]. As the predominant cellular storage site for
neutral lipids, lipid droplets play central roles for energy
metabolism, steroid biogenesis, and diet-induced obe-
sity. Yet despite their biological importance, protein
components of droplets have been identified only fairly
recently, and the cell-biological study of lipid droplets is
in its infancy. For example, lipid droplets actively move
along microtubules in cells from Drosophila to fish to
mammals [12, 18–20], but the functional significance of
this motion is unclear.
Here, we use a biochemical/proteomic approach to
identify potential regulators of droplet transport in Dro-
sophila embryos. We show that LSD2, lipid storage
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and that lack of LSD2 results in a specific transport
defect: A core transport machinery is intact because
motors remain attached to the droplets and function
relatively normally, but regulation of motion is pre-
vented. We find that LSD2 is multiply phosphorylated
in a developmentally controlled manner, that changes
in its phosphorylation state depend on the Halo protein,
and that Klar and LSD2 can physically interact. These
observations suggest that LSD2 is a crucial link be-
tween developmental signals (like Halo) and the core
motor machinery, whose activity it modifies. Because
LSD2 also plays a central role in lipid metabolism [21,
22], our results suggest a possible link between droplet
motion and the regulation of metabolism. This connec-
tion might be quite general because droplets in many
organisms move, and the mammalian homolog of
LSD2—Perilipin—also controls lipid homeostasis.
Results
Physical Isolation and Separation
of Lipid-Droplet Proteins
Lipid droplets are composed of a layer of phospholip-
ids and proteins surrounding a central core of neutral
lipids [15]. To characterize proteins physically associ-
ated with the droplets, we first purified the droplets
from Drosophila embryos with a protocol almost iden-
tical to the flotation method from Yu et al. [23]. Details
of this procedure will be published elsewhere (S. Cer-
melli et al., unpublished data).
After resuspension, proteins were separated by mo-
lecular weight and/or isoelectric point and then de-
tected by in-gel staining or Western blotting. Silver
staining of typical droplet preparations revealed several
hundred spots (Figure 1). We believe that many of them
represent bona fide droplet-associated proteins be-
cause by Western analysis, markers for several other
organelles were either absent or highly depleted in
these samples (S. Cermelli et al., unpublished data).
A Droplet-Associated Protein Whose Levels
Change during Development
Throughout the first few hours of Drosophila embryo-
genesis, lipid droplets move bidirectionally along microtu-Figure 1. Protein Profile of Isolated Lipid
Droplets
Fifty micrograms of total protein from puri-
fied lipid droplets was subjected to 2D gel
electrophoresis and then silver stained.
(A) Whole gel of phase 0 lipid droplets. The
black arrowhead corresponds to the isoelec-
tric focusing (IEF) internal standard, tropo-
myosin. The molecular weight standards are
indicated to the right. One of the spots at
44 kDa and pI 8.1 was observed to undergo
intensity changes according to the develop-
mental phase. This region of the gel is indi-
cated in (A) and shown in detail in panels
(B)–(D). This spot (red arrow) was low in
phase I (B), increased in phase II (C), and
was lower again in phase III (D). This spot
was excised and, by mass-spectroscopy,
identified as LSD2.bules, and net transport changes reproducibly [12].
Phase I, with no net transport, is followed by net plus-
end transport (phase II) and subsequently by net mi-
nus-end transport (phase III).
One potential mechanism to regulate motion is a
change in the protein composition of the droplets. We
therefore isolated lipid droplets from staged collections
of wild-type embryos (see Experimental Procedures).
Droplet proteins were separated on 2D gels and visual-
ized with silver staining (Figure 1A). The overall spot
pattern was similar for all phases, but there was a con-
sistent change: One spot was faint in phase I, strong in
phase II, and of intermediate intensity in phase III (Fig-
ures 1B–1D, arrow). This pattern repeated in three inde-
pendent experiments. The relevant spot was excised,
and its identity was determined by mass spectrometry
to be lipid storage droplet protein 2, LSD2. LSD2 is a
member of the PAT protein family of lipid-droplet-asso-
ciated proteins present in species from mammals to
slime molds [24]. One of the mammalian family mem-
bers, Perilipin, functions as a gateway molecule in neu-
tral-lipid metabolism in adipocytes [25]. Depending on
its phosphorylation state, Perilipin prevents or pro-
motes the docking of lipases to droplets and thus con-
trols the breakdown of stored lipids. Insects generally
have two family members [26], LSD1 and LSD2. In Dro-
sophila, knockouts of LSD2 impair, but do not abolish,
the ability of the animal to store neutral lipids [21, 22].
LSD2 Is Associated with Embryonic Lipid Droplets
To study LSD2’s possible role in droplet transport, we
employed several LSD2 alleles. We focused on an RNA
null allele, called LSD2KG here, that is due to a P ele-
ment insertion [22]. In some experiments, we also used
alleles 1 and 2, derived from LSD2KG and the inde-
pendent P element allele LSD2BG (Figure 2A).
With an antibody against a C-terminal LSD2 peptide,
we detected a protein of w43 kDa in embryo lysates by
Western analysis (Figure 2B), consistent with the size of
LSD2 in larval tissues [22]. Genetic controls demon-
strated that this band represents LSD2 (Figure 2B).
LSD2 protein is maternally provided (see Figure S1 in
the Supplemental Data available with this article on-
line), and in comparison to embryo lysates, it is highly
enriched in the droplet fraction (Figure 2C). In adult and
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tein Expression
(A) Structure of the LSD2 gene. Top: genomic
sequence and the exon/intron structure.
Bottom: the four mutant chromosomes ana-
lyzed for this study. KG is a P element inser-
tion (KG00149) in the 5#UTR; it is both an
RNA null [22] and a protein null (see Figure
2B) allele. BG is the insertion BG00016 [21];
it shows variable defects in clearing and
variable protein levels, and it appears to be
a weak allele. 1 and 2 are two chromo-
somes derived from KG by P element exci-
sion; homozygotes express little to no pro-
tein and have clearing defects like KG (not
shown).
(B) Expression of LSD2 by Western analysis.
Proteins were extracted from phase II em-
bryos laid by mothers of various genotypes:
+/+ = wild-type; −/− = LSD2KG homozygotes;
RK3/− = flies heterozygous for LSD2KG and Df(1)RK3, a chromosomal deletion that does not remove the LSD2 gene. RK4/− = flies heterozy-
gous for LSD2KG and Df(1)RK4, a chromosomal deletion that deletes the LSD2 gene. Proteins were separated by SDS PAGE, transferred to
membranes, and detected with antibodies against LSD2 (top) or tubulin (bottom). The anti-LSD2 antibody detects a major band in the wild-
type; this band is absent in the genotypes lacking a functional LSD2 gene.
(C) LSD2 is biochemically enriched on lipid droplets. Lipid droplets were purified by flotation with a sucrose gradient, and fractions were
taken from the very top of the gradient (LD) where lipid droplets reside and from successively lower regions (1–7). Equal volumes of these
fractions were loaded per lane, and LSD2 was detected as in (B). LSD2 was only detected in the top-most fraction, confirming that it is
entirely localized to lipid droplets. A sample of total embryo lysates (EL, left) that contained the same amount of total protein (20 µg) as the
LD fraction was loaded. LSD2 was highly enriched in the LD fraction in relation to the embryo lysate.larval tissues, LSD2-GFP fusions localize to the surface e
pof lipid droplets [22, 24], and endogenous LSD2 has
cbeen detected on lipid droplets in ovaries [21]. By
Timmunostaining, we detected LSD2 throughout the pe-
eriphery of embryos (Figure S2) in abundant round struc-
itures (Figure 3E) reminiscent in shape and size of lipid
pdroplets. By four independent criteria, these structures
aare indeed lipid droplets: First, LSD2 signal was found
cthroughout the periphery in phase I and accumulated
tbasally in phase II (Figures 3B and 3C), just like lipid
gdroplets [12]. Second, in embryos lacking the regulator
wHalo, both LSD2-positive structures (Figure 3D) and
Tlipid droplets [14] accumulate apically instead of bas-
Lally; other organelles are normally distributed [14].
wThird, when embryos are centrifuged, lipid droplets and
aassociated regulators such as Klar accumulate on one
Lside of the embryo in a droplet layer [13]. LSD2 was
oalso highly enriched in this layer (Figures 3F and 3G).
Finally, when embryos were broken to disperse embry-
Nonic organelles, LSD2 signal (green) surrounded the
wdroplets’ neutral lipid core (red) (Figures 3H and 3I). To-
egether with the Western data (Figure 2C), these obser-
uvations argue that in embryos, LSD2 is largely present
uon lipid droplets. It is possible that a small fraction of
t
embryonic LSD2 is present elsewhere; in larvae, LSD2
(
has been reported to partially localize to the ER [27]. d
Lack of LSD2 Results in Abnormal t
Droplet Distribution e
To determine whether the absence of LSD2 affected lipid- p
droplet motion, we observed embryos from LSD2KG and d
wild-type mothers by video microscopy. Changes in drop- g
let distribution cause changes in embryo transparency h
[12]: In the wild-type, net inward plus-end droplet mo- o
tion (phase II) results in a transparent embryo periphery t
(clearing), and net outward minus-end motion (phase s
III) turns embryos opaque again (clouding). In LSD2KGmbryos, the peripheral cytoplasm failed to clear com-
letely in phase II; a brownish ring persisted around the
entral yolk throughout phase II (Figures 4A and 4B).
his failure to clear was reminiscent of phase II halo−
mbryos in which apical droplet accumulation results
n a broad brownish ring visible throughout the embryo
eriphery (Figure 4C). LSD2KG embryos were intermedi-
te between halo− and wild-type (Figures 4A–4C). In re-
iprocal crosses between wild-type and LSD2KG flies,
he failure to clear completely depended only on the
enotype of the mother (data not shown), consistent
ith maternal loading of LSD2 protein into embryos.
he failure to clear correctly is likely due to the lack of
SD2 because similar clearing defects are observed
ith the alleles LSD2D1 and LSD2D2 and more weakly
nd variably for the independently isolated allele
SD2BG (Figure 2A), which produces variable amounts
f protein.
We stained embryos with the droplet-specific dye
ile red to directly compare the droplet distribution in
ild-type and LSD2KG. In phase II, droplets in wild-type
mbryos were localized basally, but they were distrib-
ted throughout the periphery of LSD2KG embryos (Fig-
res 4D and 4E). In phase III, droplets were found
hroughout the embryo periphery in both genotypes
not shown). Thus, there is little, if any, net transport of
roplets in LSD2 mutant embryos.
Lack of LSD2 affects lipid homeostasis [21, 22] and,
hus, might affect transport by generally impairing
mbryogenesis. However, embryonic development ap-
eared normal in the mutant; LSD2KG embryos un-
erwent cleavage, cellularization, gastrulation, and
ermband extension like the wild-type. Many embryos
atched, giving rise to fertile adults. The distribution of
ther cellular structures (nuclei, yolk, Golgi) was indis-
inguishable between wild-type and mutant embryos,
uggesting that other motor-driven transport is unaf-fected (Figures 4F and 4H).
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(A–D) A closeup view of the embryo periphery (basal, left; apical,
right) shows that LSD2 signal distribution is reminiscent of lipid
droplets. (A) LSD2KG phase II embryos show only background sig-
nal. (B) Wild-type phase I is shown; staining all over the periphery.
(C) Wild-type phase II is shown; signal accumulates basally. (D)
Halo− phase II embryos are shown; signal accumulates apically.
(E) Wild-type embryo, high-magnification view. LSD2 labels round
structures the size of lipid droplets.
(F and G) Wild-type embryos centrifuged to enrich lipid droplets on
the side of the embryo. Left, anti-LSD2, and right, primary antibody
omitted. LSD2 is highly enriched in the lipid-droplet layer (top right
in [F]), as detected by transmitted light microscopy (not shown).
(H and I) Lipid droplets were diluted away from other organelles by
squashing wild-type (H) or LSD2KG (I) embryos into buffer, fixed,
and treated with the droplet-specific dye Nile red (red, left) and
anti-LSD2 (green, middle). The right panels show the overlay be-
tween the two signals.
(J) LSD2 binds to the lipid-droplet targeting domain of Klar. Repre-
sentative yeast colonies grown on X-gal plates are shown. Colonies
were grown with glucose (U) or galactose (I) as a carbon source;
glucose represses LSD2 prey transcription, whereas galactose in-
duces it. Reporter-gene activity, as assayed by blue colony color-
ation, is enhanced in cells containing Klar-LD bait and either full-
length LSD2 (LSD2 FL) or LSD2 aa 78–352 (LSD2 LC) on galactose
media. Reporter-gene transcription is dependent upon Klar-LD be-
cause colonies containing a control bait and LSD2 are white. The
scale bars represent 16 µm in (A) and 4 µm in (E) and (I).Loss of LSD2 Affects Specific Parameters
of Droplet Motion
If LSD2 were responsible for motor docking, its loss
could lead to motorless droplets and, thus, lack of net
droplet transport. However, in LSD2KG embryos, drop-
lets displayed vigorous bidirectional motion as in the
wild-type (Figure 5), demonstrating that motors must
still be present. Indeed, anti-dynein Western blotsfound similar amounts of dynein in droplet preparations
from wild-type and LSD2KG embryos (Figure 4G), and
the pattern of dynein immunolocalization to droplets
was similar between the two (Figure 4I). Thus, the mo-
tors are on the droplets but are incorrectly regulated in
the absence of LSD2.
To clarify LSD2’s function, we quantified droplet mo-
tion in LSD2KG embryos and in a simultaneously ac-
quired set of wild-type data. Droplets display periods
of uninterrupted motion (“runs”) interspersed with re-
versals in directions and pauses. In the wild-type, two
classes of runs can be distinguished: short-slow runs
(low velocities, short travel distances) and long-fast
runs (higher velocities, longer travel distances). It is
predominantly the long-fast runs that are regulated to
control net transport. LSD2 mutant embryos displayed
both classes of runs, on the basis of previously estab-
lished criteria [10, 11] (see Table 1). In phase II, both
plus-end and minus-end run lengths were slightly de-
creased in relation to the wild-type (Figures 5A and 5B),
but the decrease in plus-end motion was larger, result-
ing in abolishment of net transport. This decrease in
average run length was due to a decrease in the length
of long-fast runs, rather than a change in the relative
number of long-fast versus short-slow runs (Table 1).
To specifically measure the velocities of long-fast runs,
we examined the mean velocity of runs between 500
and 1000 nm long because there are almost no short-
slow runs longer than 300 nm [11]. For both directions,
motion was slightly slower in mutant than in wild-type
embryos (Figures 5C and 5D).
Strikingly, the developmental transitions characteris-
tic of wild-type droplet motion failed to occur in the
mutant. In the wild-type, the mean run length of plus-
end motion decreases between phases II and III (Fig-
ures 5A and 5B), and the mean velocity of long plus-
end and minus-end runs decreases slightly as well (Fig-
ures 5C and 5D). Neither of these changes occurred in
LSD2KG embryos, in which the parameters of motion in
phases II and III were essentially the same (Figure 5;
Table 1). Thus, loss of LSD2 function results in the in-
ability to regulate droplet transport.
We conclude that without LSD2, the general ma-
chinery that powers droplet motion is intact because
droplets move bidirectionally with approximately nor-
mal velocities, runs have roughly the correct lengths,
and the ratio of short-slow to long-fast runs is close to
that of the wild-type. This phenotype is in direct con-
trast to that of another regulatory protein, Klar; Klar’s
loss leads to the severe alteration of many properties
of motion [12]. Thus, Klar, a proposed motor coordina-
tor, and LSD2 must play mechanistically different roles.
However, although the general machinery appears in-
tact in the absence of LSD2, the machinery’s ability to
respond to regulatory signals is impaired.
LSD2 Can Physically Interact with a Component
of the Transport Machinery
Klar is crucial for normal regulation of transport, and
its droplet localization is mediated by its C-terminal LD
domain [13]. Using Klar-LD as bait in a yeast two-hybrid
assay, we screened a cDNA library from early embryos
to identify proteins that can bind to Klar-LD. Among 33
positive clones out of 4 × 106 milion screened (D.H.K.,
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tribution of Lipid Droplets, but Not of Other
Organelles, Is Altered
(A–C) Phase II embryos inspected by bright-
field microscopy: Wild-type embryos (A), in
which lipid droplets accumulate basally, have
a much more transparent periphery than halo−
embryos (C), in which lipid droplets accumu-
late apically. Transparency of LSD2 mutants
(LSD2KG) was intermediate (B).
(D and E) Embryos were stained with the
droplet-specific dye Nile red and examined
by confocal microscopy. Yellow represents
lipid droplets, and red is a diffuse cytoplas-
mic signal. Lipid droplets accumulate basally
in the wild-type (D) and are found throughout
the periphery in the LSD2 mutant (E). The
white arrow indicates the affected region.
(F) Distributions of nuclei (blue) and Golgi
(green) are indistinguishable in wild-type
(left) and LSD2KG (right) embryos.
(G) Lysate from wild-type embryos (EL OR)
and lipid droplets from both wild-type (LD
OR) and LSD2KG embryos (LD LSD2) were
processed for Western blot analysis with
anti-Cdic (90 µg of total proteins per lane).
(H) Distribution of yolk (blue) between wild-
type (top) and LSD2KG (bottom) embryos
was indistinguishable.
(I) Lipid droplets from wild-type (left panels)
and LSD2KG (right panels) embryos were
diluted away from other organelles and unattached motors by squashing embryos in buffer. Preparations were fixed and treated with the
droplet-specific dye Nile red (red) and an antibody against Cdic, the intermediate chain of cytoplasmic dynein (green). In both cases, lipid
droplets frequently had punctate Cdic signal next to them (see [10]). The scale bar represents 4 µm.screens (Fly GRID database of 28,406 interactions;between LSD2 and Klar result in the enhancement of
Figure 5. Comparison of Motion Parameters
between Wild-Type and LSD2KG Embryos
(A and B) Droplet motion in the mutant and
wild-type displays run lengths of similar
magnitude. The decrease in length of plus-
end runs (A) observed in the wild-type be-
tween phases II and III (bars to left) fails to
occur in LSD2KG embryos (bars to right), in
which there is no change whatsoever. For
minus-end motion (B), loss of LSD2 function
results in a slight overall decrease in run
length.
(C and D) Mean velocities of lipid droplets in
wild-type and LSD2KG backgrounds are very
similar; plus-end-directed (C) and minus-
end-directed (D) motion is shown. This figure
displays velocity of runs between 500 and
1000 nm in length in order to specifically an-
alyze long-fast runs (see Loss of LSD2 Af-
fects Specific Parameters of Droplet Mo-
tion). The values in Table 1, in contrast, are
averages over all runs in a given direction.
For the wild-type, there is slight decrease in
velocity between phase II and phase III for
both directions of travel. This decrease is
absent in the LSD2KG background. Error
bars in (A)–(D) represent the SEM.J.G.G., and M.A.W., unpublished data), we isolated a t
iC-terminal fragment of LSD2. Both the library prey
clone (LSD2 LC) and a full-length LSD2 prey interact i
kwith the Klar-LD construct, but not with a control bait
lacking a cDNA insert (Figure 3J). Specific interactions Lranscription of both the lacZ and LEU2 reporter genes
n yeast (Figure 3J; data not shown). LSD2 has not been
dentified in screens of the same cDNA library for
inesin-1 interactors [28, 29], and no interactions with
SD2 have been identified in genome-wide interaction
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Mean Travel Number
Distance (nm) DS (nm) DL (nm) χ2, P(χ2) Ratio RSL Velocity (nm/s)
Minus End
Wild-type phase II (n = 1344) 575 ± 25 94 ± 7 981 ± 94 0.99, 0.50 2.0 ± 0.4 386 ± 6
LSD2KG phase II (n = 1986) 503 ± 17 83 ± 7 714 ± 47 1.24, 0.10 1.5 ± 0.3 334 ± 4
Wild-type phase III (n = 1011) 533 ± 25 77 ± 6 1154 ± 146 1.1, 0.28 2.4 ± 0.5 320 ± 6
LSD2KG phase III (n = 1351) 471 ± 19 82 ± 6 772 ± 61 1.0, 0.50 1.9 ± 0.4 333 ± 5
Plus End
Wild-type phase II (n = 1293) 624 ± 24 68 ± 5 949 ± 62 0.78, 0.85 1.5 ± 0.3 325 ± 5
LSD2KG phase II (n = 1801) 520 ± 18 74 ± 5 828 ± 52 0.96, 0.6 1.7 ± 0.3 301 ± 4
Wild-type phase III (n = 982) 441 ± 20 74 ± 7 604 ± 47 0.78, 0.85 1.4 ± 0.3 280 ± 4
LSD2KG phase III (n = 1233) 498 ± 21 75 ± 7 833 ± 93 1.35, 0.05 2.3 ± 0.6 283 ± 4
Droplet location was determined as a function of time, and then custom software was employed to parse the motion into pauses and “runs,”
that is, periods of uninterrupted motion in a given direction. The distance constants DS and DL measure the average travel distance for short-
slow and long-fast runs, respectively [10]. They result from fitting histograms of travel distance, D, to the sum of two decaying exponential
functions: y(D) = Ase−D/Ds + ALe−D/DL. The goodness of this fit is indicated by the χ2 values and their corresponding probabilities. The number
ratio RSL measures the relative frequency of short-slow in relation to long-fast runs. Indicated errors for mean travel distance and velocity
reflect the SEM, whereas the other uncertainties are derived from the fits.http://biodata.mshri.on.ca/fly_grid); thus, LSD2 does
not interact promiscuously with other proteins. This re-
sult suggests that LSD2 regulates the motors on lipid
droplets by physically interacting with the coordinator
Klar. Because both Klar and LSD2 are involved in the
regulation of transport and reside on the surface of em-
bryonic lipid droplets, we predict that these two mole-
cules interact not only in the yeast system, but also in
Drosophila embryos.
LSD2 Is Phosphorylated
in a Halo-Dependent Manner
How might LSD2 enable regulation of motor activity?
Although LSD2 had been identified owing to changes
in its pattern on 2D gels, by Western analysis, total
LSD2 levels per embryo displayed only minor changes
between phases I, II, and III (Figure 6A, EL), even when
compared to earlier stages (“phase 0”). LSD2 was also
not differentially recruited to droplets from the sur-
rounding cytoplasm in different phases because total
LSD2 levels were very similar on droplets from all phases
(Figure 6A, LD).
We therefore returned to 2D gel electrophoresis; we
separated proteins in droplet preparations by molecular
weight and isoelectric point (IEP) and subsequently
probed for LSD2 by Western analysis (Figure 6B). In all
phases, LSD2 was represented by a range of spots, of
similar molecular weight, but ranging in IEP from 6.5 to
8.5. This suggests that LSD2 can exist in multiple iso-
forms distinguished by their IEP.
To test whether some or all of these isoforms were
caused by phosphorylation, we treated the lipid-droplet
fraction proteins with alkaline phosphatase to remove
phosphate groups. All the spots of lower IEP were con-
verted into a single spot at IEP 8.5 (Figure 6C). Thus,
the right-most spot in untreated embryo lysates ap-
pears to be the unphosphorylated form of LSD2, and
the other spots are caused by addition of various num-
bers of phosphates.
The pattern of LSD2 spots changed reproducibly with
the phase of transport (Figure 6B, plus sign), raising thepossibility that these modifications are responsible for
the changes in droplet motion. We investigated a func-
tional link between LSD2 phosphorylation and droplet
motion in two ways. First, if the phosphorylation
changes regulate droplet motion, they might be spe-
cific to moving droplets. We found that two indepen-
dently isolated Drosophila cell lines, S2 and S3, contain
abundant stationary lipid droplets (not shown). Purified
lipid droplets from these cells had LSD2 that was pre-
dominantly unphosphorylated (Figure 6D). The pattern
was very similar to that of the phosphatase-treated em-
bryonic droplets (Figure 6C).
As a second test of functional relevance, we exam-
ined LSD2 phosphorylation in halo− embryos. Upregu-
lation of Halo in phase II drives net plus-end transport
[14]. Without Halo, phase II droplet motion is net minus-
end directed (Figure 4C), like wild-type phase III. In rela-
tion to the wild-type, the LSD2 on droplets from phase
II halo− embryos (Figure 6E) showed a pronounced in-
crease in spots on the left end of the spectrum, repre-
senting lower IEP. It is these spots that in the wild-type
change between phases II and III (Figure 6B). Thus, in
the absence of Halo, the phosphorylation pattern of
LSD2 in phase II approximates the pattern of the wild-
type phase III; it mimics how droplet motion itself is
altered in the absence of Halo. This observation strongly
suggests that Halo controls droplet motion at least in
part by altering LSD2’s state of phosphorylation. The
temporal correlation between upregulation of Halo and
changes in LSD2 phosphorylation is consistent with
rather direct effects of Halo on LSD2 (Figure 7).
Discussion
Using a biochemical approach, we identified a new reg-
ulator of droplet transport, LSD2, the Drosophila homo-
log of the mammalian Perilipin. In the absence of LSD2,
droplets move bidirectionally, but the embryos lose the
ability to initiate directed droplet transport. Our func-
tional analysis suggests the first outline of a regulatory
pathway for droplet motion, connecting LSD2, Halo,
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a Phase- and Halo-Dependent Manner
(A) LSD2 levels on lipid droplets purified
from different phases of development. Equal
amounts of proteins (50 g/lane) of whole
embryo lysates (EL, top) and lipid droplets
(LD, bottom), specific for each phase of de-
velopment, were separated by gel electro-
phoresis and then subjected to immunoblot
analysis with anti-LSD2. There was no signif-
icant change in overall level of LSD2 be-
tween phases.
(B) Lipid droplets from phases 0, I, II, and III
were isolated, and 65 g of protein each was
analyzed by 2D electrophoresis and Western
blotting with anti-LSD2 antibody. The 42–44
kDa region of each gel is shown; LSD2 is
present as a series of spots of varying pIs.
The plus sign indicates the location where
reproducible changes in spot intensity were
observed between phases. All these spots represent LSD2 because they are essentially gone on similar Western blots with droplet prepara-
tions from LSD2KG embryos (not shown).
(C) After phosphatase treatment (+CIP), only one isoform of LSD2 was detected by 2D gel analysis. The disappearance of the other isoforms
of LSD2, characteristic of the untreated sample (−CIP), confirmed that LSD2 is phosphorylated. In contrast to (B), the lipid droplets were
isolated from embryos representing phases 0–III in order to confirm that all the additional spots in each phase were due to phosphorylation.
(D) The LSD2 on lipid droplets purified from Drosophila S2 and S3 cells (in which droplets do not move) is not phosphorylated. Lipid droplets
from S2 cells (top) have less LSD2 than lipid droplets from S3 cells (bottom), so different amounts of total protein were used for good
detection of LSD2 (top, 110 µg; bottom, 35 µg).
(E) LSD2 expression on lipid droplets (65 g) from phase II wild-type (OR) and phase II halo− embryos (halo). The spot patterns in halo−
embryos resemble LSD2 signal from the phase III wild-type. The plus sign indicates changes in spot intensity.Klar, and phosphorylation. These observations have im- c
rplications both for the function of LSD2 and for the con-
trol of lipid distribution and metabolism. The role of
pLSD2 as a cargo-specific transport regulator may pro-
vide a paradigm for how different cargoes can employ m
rthe same set of opposite-polarity motors to move
through the same cytoplasm yet be controlled indepen- D
cdently.
c
tRegulation of Transport
sLSD2 is critical for the ability to control the direction of
tnet transport of lipid droplets because in its absence
Asuch control is lost. The physical parameters of droplet
tmotion in LSD2 mutant embryos are consistent with the
Tlack of net transport: Mean travel distances in either
tdirection are very similar to each other in both phases
dII and III.
Two observations suggest how LSD2 could mediate
ithis regulation. First, LSD2 is present on the droplets
iand can physically interact with Klar, so it could directly
tinteract with the motor machinery. Second, LSD2 is
cposttranslationally modified depending on the phase of
otransport (Figure 6). These modifications appear to be
mfunctionally important because they change with the
sphase of transport, are absent in unmoving droplets,
pand are altered in a consistent way when Halo is ab-
osent. Thus, LSD2 is likely a target of the develop-
nmentally controlled regulatory pathways that act on the
adroplet transport machinery. LSD2 is found all over the
tsurface of embryonic lipid droplets (Figure 3), whereas
mcomponents of the core motor machinery (Klar, dynein)
pare present in single punctae per droplet ([10, 13]; see
calso Figure 4). Because only a small fraction of total
rLSD2 changes its phosphorylation state from phase to
phase (Figure 6), it is likely that only the LSD2 mole- hules in the direct vicinity of the motors mediate this
egulatory signal.
LSD2 might be an integral part of the motor com-
lexes, in which it would physically touch the motor
achinery and help to position the motors in the cor-
ect 3D arrangement to each other (Figures 7A and 7B).
ifferent modified forms of LSD2 could increase or de-
rease the probability of a motor to end a run by steri-
ally favoring or disfavoring how the motor reaches the
rack (Figures 7B and 7C). Thus, without LSD2, the
witching mechanism that engages or disengages mo-
ors [10] is intact, but its properties cannot be modified.
lternatively, LSD2 could be required to position an ex-
ernal factor such as a kinase to control motor activity.
he different forms of LSD2 could then either change
heir affinity for the factor or position the kinase next to
ifferent targets.
Because LSD2 is predominantly or exclusively local-
zed to lipid droplets [21, 24, 27], and regulation fails in
ts absence, it appears to represent a key component
hat allows lipid-droplet transport to be regulated in a
argo-specific manner, independently of the transport
f other cargoes. If LSD2 relays regulatory input to the
otors, then only the motors on lipid droplets will re-
pond to these signals. LSD2 is therefore an “add-on”
rotein because the proteins responsible for motor co-
rdination and switching appear to function relatively
ormally in its absence, although they have lost the
bility to respond to their normal inputs. This interpreta-
ion suggests functional differentiation in the transport
achinery: a core complex of opposite-polarity motors,
ossibly shared between different cargoes, that re-
eives its “marching orders” through a cargo-specific
egulator not directly involved in motor function. If this
ypothesis is correct, then other cargoes should carry
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(A) In the absence of LSD2, motors are not held in the correct orien-
tation to each other.
(B) LSD2 may cluster the motors and the rest of the motor ma-
chinery into functional complexes.
(C) In response to signals, LSD2’s phosphorylation state changes,
resulting in an altered conformation. This alteration is transmitted
to the motors or coordination machinery.analogous “conductor” molecules that act to transmit
regulatory input just as LSD2 does on lipid droplets.
Conceptually, such conductor molecules are at a cru-
cial position in the pathways that regulate motion: They
are expected to be the targets of cargo-specific signal-
ing events and connect up with the core motor ma-
chinery shared between many cargoes. For lipid drop-
lets, our results suggest a pathway where the transactingsignal Halo controls the phosphorylation state of LSD2,
which in turn contacts Klar, a proposed component of
the motor machinery. This model makes testable pre-
dictions about how components of the regulatory ma-
chinery interact physically and functionally during drop-
let transport. It may also serve as a paradigm for other
cargo transport; for example, it suggests how kinase
cascades affect the activities of opposite-polarity mo-
tors. For lipid-droplet transport, several independent
lines of evidence suggest that phosphorylation of LSD2
is a key regulatory step; understanding the details of
how LSD2 phosphorylation is related to changes in
transport will therefore likely be a next crucial step for
dissecting the mechanisms of regulation.
Molecular Mechanism of LSD2 Action
LSD2 is a member of the PAT protein family, which is
present in species from slime molds to mammals [24].
All tested family members localize to the surface of lipid
droplets. Both insects and mammals express multiple
family members, suggesting that PAT proteins are func-
tionally specialized. The best-studied PAT protein is the
mammalian Perilipin, which keeps lipid breakdown to a
low level by preventing access of lipases to the drop-
lets’ neutral lipids. After hormonal signaling, Perilipin is
multiply phosphorylated, which allows lipases to dock
to the droplet surface and subsequently break down
the neutral lipids; mice lacking Perilipin display severe
defects in lipid metabolism [25, 30]. It is thought that
phosphorylation induces LSD2 conformational changes
that directly or indirectly give lipases access to the
droplet core [31].
Because LSD2 in Drosophila functions in controlling
lipid homeostasis [21, 22] similarly to Perilipin and be-
cause we found evidence for multiple, developmentally
regulated phosphorylation events, LSD2 may undergo
similar conformational changes. It is therefore possible
that a shared molecular mechanism, phosphorylation
of LSD2, controls both lipid metabolism and droplet
motion.
A Link between Transport and Lipid Homeostasis?
There has been no systematic documentation of the
extent of lipid-droplet transport, but droplets display
active motion in disparate cells, including embryos of
Drosophila and of the fish Medaka [19], in mammary
glands, and in a range of mammalian cell lines [18]. In
each case, microtubule-based transport has been im-
plicated as responsible for the motion [19, 20, 32–34].
In fibroblasts, for example, lipid droplets move bidirec-
tionally along microtubules, and the dynein cofactor
dynactin is crucial for both minus- and plus-end motion
[20], suggesting tightly coordinated motors just as in
Drosophila embryos. Because the PAT family of pro-
teins is broadly conserved, we hypothesize that like
LSD2, members of this family regulate these various
instances of lipid-droplet motion.
Is it a coincidence that lipid metabolism and microtu-
bule-based motion are controlled via the same key
molecule? Available evidence suggests functional links.
First, when lipolysis is stimulated in adipocytes, drop-
lets fragment and disperse throughout the cell [16, 35].
Fragmentation results in a vast increase in droplet sur-
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1274cface area, making attack by lipases much more effi-
bcient. Second, dispersion could put droplets in contact
pwith other organelles, such as mitochondria, important
for the catabolic breakdown of lipids. Indeed, mito- P
chondria often surround lipid droplets in clusters [36]. D
The mechanisms leading to fragmentation and disper- [
sion are unknown, but active pulling by motors to de-
form and move droplets is an intriguing possibility.
SWhen lipolysis is stimulated, many proteins are newly
Drecruited to the droplets, among them Rab proteins
u
[35], a class of proteins with roles in regulating cargo f
transport [37, 38].
This emerging link between the physical motion of A
droplets and lipid metabolism opens exciting new pos-
Wsibilities: Perhaps impaired droplet transport contrib-
Outes to metabolic diseases. Once we understand the
hmechanisms underlying droplet motion, it will be pos-
t
sible to specifically disrupt droplet motion and directly I
test its contribution to lipid metabolism. t
C
tConclusion
cWe find that the lipid-droplet-associated protein LSD2
S
is required to regulate the motor-driven motion of lipid
droplets in Drosophila embryos. In its absence, drop-
Rlets move in a robust way, but their motion cannot be
A
regulated. These observations suggest that it is pos- P
sible to separate the mechanisms that govern bidirec-
tional transport into two functionally distinct but related R
parts: a motor-control cassette that turns motors on
and off and a regulatory cassette that is cargo specific
and controls when and how the motor-control cassette
alters its activity. For lipid droplets, we propose that
LSD2 is an essential component of this regulatory cas-
sette and that the functional state of the regulatory cas-
sette is in part controlled by Halo-dependent changes
in LSD2 phosphorylation. LSD2, like its mammalian ho-
molog Perilipin, can also control lipid homeostasis,
suggesting the intriguing possibility that droplet motion
plays a role in the control of lipid metabolism.
Experimental Procedures
Embryo Collection
Embryos were collected for 1 hr and aged for various times (1.5 hr,
2.5 hr, and 3.5 hr) to obtain samples highly enriched in phase I,
phase II, or phase III embryos, respectively. An initial embryo col-
lection was discarded to eliminate fertilized eggs that females
might have been storing.
Isolation of Lipid Droplets by Subcellular Fractionation
Lipid droplets were purified as described [23] with few modifica-
tions. In brief, embryo or cell lysates were loaded on a sucrose
gradient solution. After ultracentrifugation, the buoyant lipid drop-
lets were collected from the top of the gradient. Isolated lipid drop-
lets were either solubilized in SDS-containing buffer for subsequent
SDS-PAGE or resuspended in RIPA buffer (25 mM HEPES, 1%
deoxycholate, 1% NP-40, 0.2% SDS, 1 mM sodium orthovanadate,
glycerol, and 30 mM sodium pyrophosphate) for 2D gel electropho- 1
resis. For details on the 2D electrophoresis, phosphatase treat-
ment, and immunoblot analysis, see the Supplemental Experimen-
tal Procedures. 1
Anti-LSD2 Antibody
Rabbits were repeatedly immunized with the peptide GTNVEQSG 1
GSSSDACSP (aa 296–312 in the LSD2 protein sequence) by a com-
mercial facility (Washington Biotechnology). Crude serum was used
for immunoblotting. For immunocytochemistry, serum was first in-ubated with fixed LSD2KG embryos to remove crossreacting anti-
odies. Immunostaining was performed with a variation of standard
rocedures (see Supplemental Experimental Procedures).
article Tracking and Analysis
roplet motion was recorded and analyzed essentially as described
10]. See the Supplemental Experimental Procedures for details.
upplemental Data
etailed Experimental Procedures, as well as two supplemental fig-
res, are available at http://www.current-biology.com/cgi/content/
ull/15/14/1266/DC1/.
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